Skip to content

A study of dermatological efficacy of topical product(BSL02-150929Y) in human skin

A study of dermatological efficacy of topical product(BSL02-150929Y) in human skin - A study of dermatological efficacy of topical product(BSL02-150929Y) in human skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019152
Enrollment
10
Registered
2015-10-23
Start date
2015-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

1) Topical application of both test product and control product for 3wks. 2) UVB irradiation to applied areas after 2wks application

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Healthy males

Exclusion criteria

Exclusion criteria: 1)Individuals who have some skin diseases 2)Individuals who have some skin troubles in applied positions 3)Individuals who already get dark skin with excessive sunburn 4)Individuals who play outdoor actions with excessive sunburn routinely 5)Individuals who have some diseases (endocrine, liver, kidney, heart and blood pressure and so on) and administer treatments and medications 6)Individuals who apply cosmetics and drugs for beauty to target skins, and take drugs for improvement of fleck, age spot and suntan 7)Smoker 8)Individuals who are judged inappropriate for the study by study director and/or study doctor

Design outcomes

Primary

MeasureTime frame
Following 2 weeks application of skin care preparations to upper arms, I. Degree of erythema 1 day after UVB irradiation. II. Skin color 1 week after UVB irradiation.

Countries

Japan

Contacts

Public ContactKatsuyuki Yuki

Kao Corporation R&D-Core Technology- Biological Science Research

yuki.katsuyuki@kao.co.jp0285-68-7460

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026